Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 30, 2017)
Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017
This bill amends the Internal Revenue Code to allow tax credits for 50% of the clinical testing expenses for: (1) infectious disease products that are intended to treat a serious or life-threatening infection, including one caused by an antibacterial or antifungal resistant pathogen or a qualifying pathogen listed by the Department of Health and Human Services as having the potential to pose a serious threat to public health; and (2) in-vitro diagnostic devices that identify in less than four hours the presence, concentration, or characteristics of a serious or life-threatening infection.
What just happenedMar 30, 2017
Referred to the House Committee on Ways and Means.
Who’s behind it
- Introduced in HouseMar 30, 2017
- Mar 30, 2017IntroReferralH11100
Referred to the House Committee on Ways and Means.
Ways and Means Committee - Mar 30, 2017IntroReferralIntro-H
Introduced in House
- Mar 30, 2017IntroReferral1000
Introduced in House